Syngenta Receives Approval for New Corn Technologies in Brazil

BASEL, Switzerland, Nov. 13 /PRNewswire-FirstCall/ --

-- MIR162 corn and Bt11xGA21 stacked corn receive approvals
-- Brazilian growers to gain increased competitiveness and productivity

-- Further strengthens Syngenta portfolio in Brazilian market

Syngenta announced today that its genetically modified corn traits MIR162 and
Bt11xGA21 are now fully approved for cultivation in Brazil. This follows the
approval by the National Biosafety Committee and the thirty day clearance
period. The approval of these advanced technologies will offer Brazilian
growers increased productivity, higher grain quality and reduced production
costs.

"These approvals reinforce Syngenta's leading position in technology and
innovation, strengthen our portfolio of solutions and will enable Brazilian
growers to increase their efficiency and global competitiveness," said Davor
Pisk, Chief Operating Officer Seeds.

The efficacy and broad spectrum of MIR162 make it the most advanced technology
available today to control the fall army worm, the main insect threat to corn
in Brazil. The stacked corn trait Bt11xGA21 offers higher value and
convenience for growers through combined insect resistance and herbicide
tolerance.

Syngenta is one of the world's leading companies with more than 24,000
employees in over 90 countries dedicated to our purpose: Bringing plant
potential to life. Through world-class science, global reach and commitment
to our customers we help to increase crop productivity, protect the
environment and improve health and quality of life. For more information
about us please go to www.syngenta.com or www.growmorefromless.com.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by
terminology such as 'expect', 'would', 'will', 'potential', 'plans',
'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such
statements may be subject to risks and uncertainties that could cause the
actual results to differ materially from these statements. We refer you to
Syngenta's publicly available filings with the U.S. Securities and Exchange
Commission for information about these and other risks and uncertainties.
Syngenta assumes no obligation to update forward-looking statements to reflect
actual results, changed assumptions or other factors. This document does not
constitute, or form part of, any offer or invitation to sell or issue, or any
solicitation of any offer, to purchase or subscribe for any ordinary shares in
Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on
in connection with, any contract therefore.

Syngenta International AG

Media Office
CH-4002 Basel
Switzerland
Tel: +41 61 323 23 23
Fax: +41 61 323 24 24

www.syngenta.com

Media contact:

Medard Schoenmaeckers
Switzerland +41 61 323 2323

Analyst/Investor contacts:

Jennifer Gough
Switzerland +41 61 323 5059
USA +1 202 737 6521

John Hudson
Switzerland +41 61 323 6793
USA +1 202 737 6520

SOURCE Syngenta

Media Office of Syngenta International AG, +41 61 323 23 23, Fax, +41 61 323
24 24; or Media, Medard Schoenmaeckers, Switzerland, +41 61 323 2323; or
Analysts/Investors, Jennifer Gough, Switzerland, +41 61 323 5059, USA
+1-202-737-6521, or John Hudson, Switzerland +41 61 323 6793, USA,
+1-202-737-6520